Prime Capital Investment Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,188
| Closed | -$216K | – | 1067 |
|
|
2024
Q4 | $216K | Buy |
+5,188
| New | +$216K | ﹤0.01% | 835 |
|
|
2024
Q3 | – | Sell |
-3,613
| Closed | -$429K | – | 937 |
|
|
2024
Q2 | $429K | Sell |
3,613
-906
| -20% | -$108K | 0.01% | 618 |
|
|
2024
Q1 | $482K | Sell |
4,519
-7,733
| -63% | -$824K | 0.01% | 625 |
|
|
2023
Q4 | $1.22M | Sell |
12,252
-5,021
| -29% | -$499K | 0.02% | 400 |
|
|
2023
Q3 | $1.78M | Sell |
17,273
-9,273
| -35% | -$958K | 0.04% | 263 |
|
|
2023
Q2 | $3.23M | Buy |
26,546
+12,487
| +89% | +$1.52M | 0.06% | 213 |
|
|
2023
Q1 | $2.16M | Sell |
14,059
-9,116
| -39% | -$1.4M | 0.09% | 159 |
|
|
2022
Q4 | $4.16M | Buy |
23,175
+15,897
| +218% | +$2.86M | 0.16% | 116 |
|
|
2022
Q3 | $861K | Sell |
7,278
-15,009
| -67% | -$1.78M | 0.05% | 185 |
|
|
2022
Q2 | $3.18M | Buy |
22,287
+17,556
| +371% | +$2.51M | 0.19% | 94 |
|
|
2022
Q1 | $1.2M | Hold |
4,731
| – | – | 0.07% | 162 |
|
|
2021
Q4 | $1.2M | Sell |
4,731
-8,042
| -63% | -$2.04M | 0.06% | 166 |
|
|
2021
Q3 | $4.92M | Buy |
+12,773
| New | +$4.92M | 0.31% | 62 |
|
|
2021
Q2 | – | Sell |
-1,135
| Closed | -$149K | – | 483 |
|
|
2021
Q1 | $149K | Sell |
1,135
-117
| -9% | -$15.4K | 0.01% | 264 |
|
|
2020
Q4 | $131K | Sell |
1,252
-8,773
| -88% | -$918K | 0.01% | 259 |
|
|
2020
Q3 | $709K | Sell |
10,025
-49,995
| -83% | -$3.54M | 0.06% | 169 |
|
|
2020
Q2 | $3.85M | Buy |
60,020
+59,320
| +8,474% | +$3.81M | 0.36% | 58 |
|
|
2020
Q1 | $21K | Buy |
+700
| New | +$21K | ﹤0.01% | 355 |
|